Prognostic models for renal cell carcinoma recurrence: External validation in a Japanese population - Abstract

Department of Urology, Chiba University Graduate School of Medicine Prostate Center and Division of Urology, Chiba Cancer Center, Chiba, Japan.

Department of Urology, Toho University Sakura Medical Center, Sakura, Japan.

 

 

The aim of the present study was to compare the accuracy of three prognostic models in predicting recurrence-free survival among Japanese patients who underwent nephrectomy for non-metastatic renal cell carcinoma (RCC). Patients originated from two centers: Chiba University Hospital (n = 152) and Chiba Cancer Center (n = 65). The following data were collected: age, sex, clinical presentation, Eastern Cooperative Oncology Group performance status, surgical technique, 1997 tumor-node-metastasis stage, clinical and pathological tumor size, histological subtype, disease recurrence, and progression. Three western models, including Yaycioglu's model, Cindolo's model and Kattan's nomogram, were used to predict recurrence-free survival. Predictive accuracy of these models were validated by using Harrell's concordance-index. Concordance-indexes were 0.795 and 0.745 for Kattan's nomogram, 0.700 and 0.634 for Yaycioglu's model, and 0.700 and 0.634 for Cindolo's model, respectively. Furthermore, the constructed calibration plots of Kattan's nomogram overestimated the predicted probability of recurrence-free survival after 5 years compared with the actual probability. Our findings suggest that despite working better than other predictive tools, Kattan's nomogram needs be used with caution when applied to Japanese patients who have undergone nephrectomy for non-metastatic RCC.

Written by:
Utsumi T, Ueda T, Fukasawa S, Komaru A, Sazuka T, Kawamura K, Imamoto T, Nihei N, Suzuki H, Ichikawa T.   Are you the author?

Reference: Int J Urol. 2011 Jul 26. Epub ahead of print.
doi: 10.1111/j.1442-2042.2011.02812.x

PubMed Abstract
PMID: 21790791

UroToday.com Renal Cancer Section